AIM ImmunoTech Approaches Major Clinical Inflection Point with Phase 2 Pancreatic Cancer Data Expected Q1 2027; Reports Third Quarter 2026 Financial Results
GlobeNewswire · 财报与经营业绩 · November 13, 2026 at 8:30 AM ET
Read the full report at the original publisher.